Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD + protects the heart against pressure overload

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yano, Masamichi ^a   Akazawa, Hiroshi ^b,d   Oka, Toru ^a,d   Yabumoto, Chizuru ^a,c   Kudo Sakamoto, Yoko ^a   Kamo, Takehiro ^b   Shimizu, Yu ^b   Yagi, Hiroki ^b   Naito, Atsuhiko T ^a,b,d   Lee, Jong Kook ^a,d   Suzuki, Jun Ichi ^b   Sakata, Yasushi ^a   Komuro, Issei ^b,d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, MOUSE; PROTECTIVE AGENT; SIRTUIN 1;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARDIAC MUSCLE; HEART; MALE; METABOLISM; MONOCYTE; MOUSE; PHYSIOLOGY; SYNTHESIS; UPREGULATION;

ANIMALS; CYTOKINES; HEART; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; MYOCARDIUM; NAD; NICOTINAMIDE MONONUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTECTIVE AGENTS; SIRTUIN 1; UP-REGULATION;

EID: 84946595378     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15857     Document Type: Article

References (36)

1. Ussher, J. R., Jaswal, J. S. & Lopaschuk, G. D. Pyridine nucleotide regulation of cardiac intermediary metabolism. Circ Res 111, 628-641 (2012).
2. Belenky, P., Bogan, K. L. & Brenner, C. NAD+ metabolism in health and disease. Trends Biochem Sci 32, 12-19 (2007).
3. Stein, L. R. & Imai, S. The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrin Met 23, 420-428 (2012).
4. Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13, 225-238 (2012).
5. Houtkooper, R. H., Canto, C., Wanders, R. J. & Auwerx, J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31, 194-223 (2010).
6. Revollo, J. R., Grimm, A. A. & Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279, 50754-50763 (2004).
7. Revollo, J. R., et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6, 363-375 (2007).
8. Imai, S. & Yoshino, J. The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metab 15 Suppl 3, 26-33 (2013).
9. Pillai, V. B., et al. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling. Am J Physiol Heart Circ Physiol 304, H415-426 (2013).
10. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+ ) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab 14, 528-536 (2011).
11. Hsu, C. P., Oka, S., Shao, D., Hariharan, N. & Sadoshima, J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 105, 481-491 (2009).
12. Yamamoto, T., et al. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PloS one 9, e98972 (2014).
13. Octavia, Y., et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52, 1213-1225 (2012).
14. Hasmann, M. & Schemainda, I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63, 7436-7442 (2003).
15. Abdellatif, M. Sirtuins and pyridine nucleotides. Circ Res 111, 642-656 (2012).
16. Planavila, A., et al. Dilated cardiomyopathy and mitochondrial dysfunction in Sirt1-deficient mice: a role for Sirt1-Mef2 in adult heart. J Mol Cell Cardiol 53, 521-531 (2012).
17. Swirski, F. K., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616 (2009).
18. Ferenbach, D. A., et al. Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice. Kidney Int 82, 928-933 (2012).
19. Xiao, J., Sun, B., Li, M., Wu, Y. & Sun, X. B. A novel adipocytokine visfatin protects against H(2)O(2) -induced myocardial apoptosis: a missing link between obesity and cardiovascular disease. J Cell Physiol 228, 495-501 (2013).
20. Lim, S. Y., et al. The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med 12, 1395-1403 (2008).
21. Montecucco, F., et al. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. Antioxid Redox Signal 18, 630-641 (2013).
22. Hsu, C. P., et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122, 2170-2182 (2010).
23. Alcendor, R. R., et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100, 1512-1521 (2007).
24. Kawashima, T., et al. Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice. J Mol Cell Cardiol 51, 1026-1036 (2011).
25. Rodgers, J. T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118 (2005).
26. Tanno, M., et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285, 8375-8382 (2010).
27. Luo, J., et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148 (2001).
28. Hariharan, N., et al. Deacetylation of FoxO by Sirt1 Plays an Essential Role in Mediating Starvation-Induced Autophagy in Cardiac Myocytes. Circ Res 107, 1470-1482 (2010).
29. Oka, S., et al. PPARalpha-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab 14, 598-611 (2011).
30. Ramsey, K. M., Mills, K. F., Satoh, A. & Imai, S. Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell 7, 78-88 (2008).
31. Wang, P., et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 69, 360-374 (2011).
32. Gomes, A. P., et al. Declining NAD(+ ) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624-1638 (2013).
33. Lazzarini, V., Mentz, R. J., Fiuzat, M., Metra, M. & O'Connor, C. M. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail 15, 717-723 (2013).
34. Bobbert, P., et al. Nicotinamide Phosphoribosyltransferase/Pre-B-Cell Colony Enhancing Factor/Visfatin Plasma Levels and Clinical Outcome in Patients With Dilated Cardiomyopathy. J Card Fail 21, 330-338 (2015).
35. Kawai, S., Takagi, Y., Kaneko, S. & Kurosawa, T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp Anim 60, 481-487 (2011).
36. Bruzzone, S., et al. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PloS one 4, e7897 (2009).